Literature DB >> 16971795

Effect of microbubble ligation to cells on ultrasound signal enhancement: implications for targeted imaging.

Miles Lankford1, Carolyn Z Behm, James Yeh, Alexander L Klibanov, Peter Robinson, Jonathan R Lindner.   

Abstract

OBJECTIVES: Molecular imaging with contrast-enhanced ultrasound (CEU) relies on the detection of microbubbles retained in regions of disease. The aim of this study was to determine whether microbubble attachment to cells influences their acoustic signal generation and stability.
MATERIALS AND METHODS: Biotinylated microbubbles were attached to streptavidin-coated plates to derive density versus intensity relations during low- and high-power imaging. To assess damping from microbubble attachment to solid or cell surfaces, in vitro imaging was performed for microbubbles charge-coupled to methacrylate spheres and for vascular cell adhesion molecule-1-targeted microbubbles attached to endothelial cells.
RESULTS: Signal enhancement on plates increased according to acoustic power and microbubble site density up to 300 mm. Microbubble signal was reduced by attachment to solid spheres during high- and low-power imaging but was minimally reduced by attachment to endothelial cells and only at low power.
CONCLUSION: Attachment of targeted microbubbles to rigid surfaces results in damping and a reduction of their acoustic signal, which is not seen when microbubbles are attached to cells. A reliable concentration versus intensity relationship can be expected from microbubble attachment to 2-dimensional surfaces until a very high site density is reached.

Entities:  

Mesh:

Year:  2006        PMID: 16971795     DOI: 10.1097/01.rli.0000236825.72344.a9

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  12 in total

1.  Contrast-enhanced ultrasound: The evolving applications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

2.  A sensitive TLRH targeted imaging technique for ultrasonic molecular imaging.

Authors:  Xiaowen Hu; Hairong Zheng; Dustin E Kruse; Patrick Sutcliffe; Douglas N Stephens; Katherine W Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010       Impact factor: 2.725

3.  Molecular imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model.

Authors:  Julius L Decano; Anne Marie Moran; Nelson Ruiz-Opazo; Victoria L M Herrera
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 4.  Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography.

Authors:  Jonathan R Lindner
Journal:  Nat Rev Cardiol       Date:  2009-06-09       Impact factor: 32.419

Review 5.  Molecular imaging with targeted contrast ultrasound.

Authors:  Mark Piedra; Achim Allroggen; Jonathan R Lindner
Journal:  Cerebrovasc Dis       Date:  2009-04-16       Impact factor: 2.762

Review 6.  Molecular imaging of disease with targeted contrast ultrasound imaging.

Authors:  Yoichi Inaba; Jonathan R Lindner
Journal:  Transl Res       Date:  2012-01-04       Impact factor: 7.012

Review 7.  Molecular imaging of cardiovascular disease using ultrasound.

Authors:  Flordeliza S Villanueva
Journal:  J Nucl Cardiol       Date:  2008 Jul-Aug       Impact factor: 5.952

8.  Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy.

Authors:  Zhonggao Gao; Anne M Kennedy; Douglas A Christensen; Natalya Y Rapoport
Journal:  Ultrasonics       Date:  2007-11-19       Impact factor: 2.890

9.  Effect of acoustic power on in vivo molecular imaging with targeted microbubbles: implications for low-mechanical index real-time imaging.

Authors:  Beat A Kaufmann; Chad L Carr; Todd Belcik; Aris Xie; Benjamin Kron; Qi Yue; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2009-11-11       Impact factor: 5.251

Review 10.  Ultrasound molecular imaging of cardiovascular disease.

Authors:  Flordeliza S Villanueva; William R Wagner
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.